1. Home
  2. BCLI vs SQFT Comparison

BCLI vs SQFT Comparison

Compare BCLI & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
    SELLHOLDBUYas of 7 hours ago
  • SQFT
    SELLHOLDBUYas of 7 hours ago
  • Stock Information
  • Founded
  • BCLI 2000
  • SQFT 1999
  • Country
  • BCLI United States
  • SQFT United States
  • Employees
  • BCLI N/A
  • SQFT N/A
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • SQFT Real Estate Investment Trusts
  • Sector
  • BCLI Health Care
  • SQFT Real Estate
  • Exchange
  • BCLI Nasdaq
  • SQFT Nasdaq
  • Market Cap
  • BCLI 9.1M
  • SQFT 9.8M
  • IPO Year
  • BCLI N/A
  • SQFT 2020
  • Fundamental
  • Price
  • BCLI $2.07
  • SQFT $0.79
  • Analyst Decision
  • BCLI Strong Buy
  • SQFT
  • Analyst Count
  • BCLI 1
  • SQFT 0
  • Target Price
  • BCLI $30.00
  • SQFT N/A
  • AVG Volume (30 Days)
  • BCLI 128.7K
  • SQFT 206.8K
  • Earning Date
  • BCLI 11-14-2024
  • SQFT 12-31-2024
  • Dividend Yield
  • BCLI N/A
  • SQFT N/A
  • EPS Growth
  • BCLI N/A
  • SQFT N/A
  • EPS
  • BCLI N/A
  • SQFT N/A
  • Revenue
  • BCLI N/A
  • SQFT $18,586,052.00
  • Revenue This Year
  • BCLI N/A
  • SQFT N/A
  • Revenue Next Year
  • BCLI N/A
  • SQFT N/A
  • P/E Ratio
  • BCLI N/A
  • SQFT N/A
  • Revenue Growth
  • BCLI N/A
  • SQFT 5.44
  • 52 Week Low
  • BCLI $1.05
  • SQFT $0.47
  • 52 Week High
  • BCLI $11.85
  • SQFT $1.39
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 59.27
  • SQFT 55.92
  • Support Level
  • BCLI $1.45
  • SQFT $0.71
  • Resistance Level
  • BCLI $2.45
  • SQFT $0.85
  • Average True Range (ATR)
  • BCLI 0.22
  • SQFT 0.10
  • MACD
  • BCLI 0.09
  • SQFT 0.01
  • Stochastic Oscillator
  • BCLI 63.11
  • SQFT 72.47

Stock Price Comparison Chart: BCLI vs SQFT

BCLI
SQFT
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0123456789101112BCLI VS SQFT

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use